Continuous Infusion of the CXCR4 Antagonist Plerixafor for WHIM Syndrome
David H. McDermott, Shamik Majumdar, Daniel S. Velez, Elena Cho, Zhanzhou Li, Ji-Liang Gao, Megan C. Grieco, M. Lawrence, Susana L. Silva, Leslie Castelo-Soccio, Dean Follmann, Philip M. Murphy
This study evaluates continuous subcutaneous plerixafor infusion in WHIM syndrome patients, showing improved leukocyte counts, wart regression, and patient preference over daily injections.
Journal of Clinical Immunology · Mar 29, 2026Peer-reviewedGenetic & Genomic Medicine